P H Groop - JoVE Visualize

Showing results (111-120 of 125) with videos related to

Pageof 13

Sort By:

Diabetologia|October 8, 2005

Polymorphisms in the gene encoding angiotensin I converting enzyme 2 and diabetic nephropathyS Fröjdö, L Sjölind, M Parkkonen, et al.

Diabetologia|May 31, 2012

SNP in the genome-wide association study hotspot on chromosome 9p21 confers susceptibility to diabetic nephropathy in type 1 diabetesE Fagerholm, E Ahlqvist, C Forsblom, et al.

Journal of Internal Medicine|January 3, 2013

Triglyceride-cholesterol imbalance across lipoprotein subclasses predicts diabetic kidney disease and mortality in type 1 diabetes: the FinnDiane StudyV-P Mäkinen, P Soininen, A J Kangas, et al.

Journal of Internal Medicine|July 13, 2013

Associations and interactions between lipid profiles, retinopathy and nephropathy in patients with type 1 diabetes: the FinnDiane StudyN Tolonen, K Hietala, C Forsblom, et al.

The Journal of Nutrition, Health & Aging|July 28, 2012

Mild cognitive impairment associates with concurrent decreases in serum cholesterol and cholesterol-related lipoprotein subclassesT Tukiainen, P Jylänki, V P Mäkinen, et al.

Diabetologia|December 2, 1998

Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4C M Forsblom, T Sane, P H Groop, et al.

Cell Death & Disease|May 8, 2015

Podocyte apoptosis is prevented by blocking the Toll-like receptor pathwayP Saurus, S Kuusela, E Lehtonen, et al.

Diabetologia|November 13, 2009

Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction ruleY Vergouwe, S S Soedamah-Muthu, J Zgibor, et al.

Diabetologia|August 17, 2010

A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitusA Alkhalaf, S J L Bakker, H J G Bilo, et al.

Diabetologia|July 26, 2006

Utilisation of antihyperglycaemic drugs in ten European countries: different developments and different levelsA Melander, P Folino-Gallo, T Walley, et al.

Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:

Pageof 13

Diabetologia|October 8, 2005

Polymorphisms in the gene encoding angiotensin I converting enzyme 2 and diabetic nephropathyS Fröjdö, L Sjölind, M Parkkonen, et al.

Diabetologia|May 31, 2012

SNP in the genome-wide association study hotspot on chromosome 9p21 confers susceptibility to diabetic nephropathy in type 1 diabetesE Fagerholm, E Ahlqvist, C Forsblom, et al.

Journal of Internal Medicine|January 3, 2013

Triglyceride-cholesterol imbalance across lipoprotein subclasses predicts diabetic kidney disease and mortality in type 1 diabetes: the FinnDiane StudyV-P Mäkinen, P Soininen, A J Kangas, et al.

Journal of Internal Medicine|July 13, 2013

Associations and interactions between lipid profiles, retinopathy and nephropathy in patients with type 1 diabetes: the FinnDiane StudyN Tolonen, K Hietala, C Forsblom, et al.

The Journal of Nutrition, Health & Aging|July 28, 2012

Mild cognitive impairment associates with concurrent decreases in serum cholesterol and cholesterol-related lipoprotein subclassesT Tukiainen, P Jylänki, V P Mäkinen, et al.

Diabetologia|December 2, 1998

Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4C M Forsblom, T Sane, P H Groop, et al.

Cell Death & Disease|May 8, 2015

Podocyte apoptosis is prevented by blocking the Toll-like receptor pathwayP Saurus, S Kuusela, E Lehtonen, et al.

Diabetologia|November 13, 2009

Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction ruleY Vergouwe, S S Soedamah-Muthu, J Zgibor, et al.

Diabetologia|August 17, 2010

A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitusA Alkhalaf, S J L Bakker, H J G Bilo, et al.

Diabetologia|July 26, 2006

Utilisation of antihyperglycaemic drugs in ten European countries: different developments and different levelsA Melander, P Folino-Gallo, T Walley, et al.

Pageof 13